NORFIELD CAPITAL, LLC

Company

Insight Molecular Diagnostics Inc.

Filed

November 25, 2022

Accession Number

0001085146-22-004203

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →